XORTX Therapeutics XRTX
NASDAQ XRTX
$1.69 -0.01 (-0.59%)
At close: Sep 30, 2026 · 4:00 PM EDT

XORTX Therapeutics (XRTX) Shares Outstanding (2020 - 2026)

Updated

XORTX Therapeutics' Shares Outstanding came in at 946,927 for the quarter ended Jun 30, 2026, up 64.5% from 575,703 a year earlier and unchanged from the prior quarter.

Analysis

XORTX Therapeutics (XRTX) Shares Outstanding (2020 - 2026) Analysis & Trends

Going back to the quarter ended Mar 31, 2020, XORTX Therapeutics' Shares Outstanding data covers 26 quarters.

  • Shares Outstanding has increased in each of the last six years, with a five-year compound annual growth rate of 44.9% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Shares Outstanding was 575,703 in the year ended Dec 31, 2024 (+45.3%), 396,347 in the year ended Dec 31, 2023 (+33.9%), 295,980 in the year ended Dec 31, 2022 (+35.3%) and 218,834 in the year ended Dec 31, 2021 (+47.8%).
  • Year-over-year, Shares Outstanding has increased for 22 consecutive quarters, with growth averaging 51.0% over the last eight quarters.
  • The year-over-year growth in Shares Outstanding has ranged between 24.3% (the quarter ended Sep 30, 2021) and 64.5% (the quarter ended Jun 30, 2026) over the last five years.
  • Business Quant data shows XRTX's Shares Outstanding at 946,927 (quarter ended Mar 31, 2026), 946,927 (quarter ended Dec 31, 2025) and 575,703 (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.94 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.55 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.70 Mn
10 XORTX Therapeutics 1.60 Mn -1.70 Mn - 946,927.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 946,927.00
Mar 31, 2026 946,927.00
Dec 31, 2025 946,927.00
Sep 30, 2025 575,703.00
Jun 30, 2025 575,703.00
Mar 31, 2025 575,703.00
Dec 31, 2024 575,703.00
Sep 30, 2024 396,347.00
Jun 30, 2024 396,347.00
Mar 31, 2024 396,347.00
Dec 31, 2023 396,347.00
Sep 30, 2023 295,980.00
Jun 30, 2023 295,980.00
Mar 31, 2023 295,980.00
Dec 31, 2022 295,980.00
Sep 30, 2022 218,834.00
Jun 30, 2022 218,834.00
Mar 31, 2022 218,834.00
Dec 31, 2021 218,834.00
Sep 30, 2021 148,088.00
API Access

XORTX Therapeutics Shares Outstanding API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding&ticker=XRTX&period=max&api_key=YOUR_API_KEY